Skip to main content
IMUGENE LIMITED logo

IMUGENE LIMITED — Investor Relations & Filings

Ticker · IMU ISIN · AU000000IMU9 LEI · 984500A5C9KF08EAF248 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,444 across all filing types
Latest filing 2008-01-22 Capital/Financing Update
Country AU Australia
Listing ASX IMU

About IMUGENE LIMITED

https://imugene.com

Imugene Limited is a clinical-stage immuno-oncology company focused on developing immunotherapies to activate the immune system against various cancers. The company’s pipeline features multiple platform technologies, including B-cell activating immunotherapies, oncolytic viruses, and CAR-T cell enhancement therapies. Key clinical candidates include HER-Vaxx, targeting HER2-positive gastric cancer, and PD1-Vaxx, a checkpoint inhibitor immunotherapy. Imugene is also advancing the CF33 oncolytic virus platform, which includes VAXINIA and CHECKvacc, alongside the onCARlytics program. The onCARlytics platform is designed to enable CAR-T cells to target solid tumors by inducing the expression of CD19 on cancer cell surfaces. These programs aim to address unmet needs in oncology by providing targeted, potent, and potentially less toxic alternatives to conventional treatments.

Recent filings

Filing Released Lang Actions
Rights Issue s708A Notice and Appx 3B 9 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated 22 January 2008 regarding the allotment of shares under a rights issue, including an Appendix 3B form which is a standard new issue announcement and application for quotation of additional securities on the ASX. It details the number of shares issued, the terms of the securities, underwriting fees, and compliance with the Corporations Act 2001. The document is focused on the issuance and quotation of new shares and the related regulatory notices. It does not contain financial statements, management discussion, or earnings data. It is not a report but an announcement of a capital raising event and related securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP).
2008-01-22 English
Rights Issue - Notification of Shortfall 1 page ?Kb
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 18 January 2008 regarding a Rights Issue - Notification of Shortfall. It details the acceptance rate of the entitlement offer, the number of shares taken up, and the underwritten shortfall to be placed by underwriters. The document is relatively short (2302 characters) and focuses on a capital raising event, specifically a rights issue and the shortfall notification. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. It is not a full financial report, earnings release, or regulatory filing, but a specific announcement about financing activity.
2008-01-17 English
Letter to Shareholders 2 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to shareholders regarding a non-renounceable rights issue, including details about entitlement forms, offer documents, and instructions for applying for shares. It is a shareholder communication about a capital raising event, specifically a rights issue offering shares at a discount. The document does not contain financial statements or detailed financial analysis, nor is it a full report. It is an announcement related to financing activities and capital structure changes. Therefore, it fits best under the category 'Capital/Financing Update' (CAP). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high given the clear content and context.
2007-12-16 English
Non-Renounceable Rights Issue 11 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated December 2007 regarding a non-renounceable rights issue by Imugene Limited. It includes detailed information about the offer, terms, timetable, underwriting, use of funds, and eligibility. The content focuses on the company's capital raising activity through issuing new shares to existing shareholders. There is no financial statement or earnings data presented, nor is it a report or presentation. The document is a formal announcement of a capital raising event and related offer details, which fits the category of Capital/Financing Update (CAP). The document length is substantial and contains substantive details about the rights issue, not merely a brief notice or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2007-12-10 English
Non-renounceable Rights Issue 5 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated December 3, 2007, detailing a fully underwritten non-renounceable rights issue by Imugene. It includes specifics about the offer terms, pricing, record date, use of funds, underwriting agreement, timetable, and regulatory notices under the Corporations Act 2001. The content focuses on capital raising activities, share issuance, and underwriting arrangements. There are no financial statements or detailed financial performance data presented, nor is this a report or presentation of earnings or management discussion. The document is clearly an announcement related to a capital raising event, specifically a rights issue, which fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the rights issue, underwriting, and timetable, confirming it is not a brief notice or a report publication announcement. Therefore, the appropriate classification is CAP with high confidence.
2007-12-02 English
Appendix 3B 8 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the number of shares issued, issue price, purpose of the issue, underwriting details, and application for quotation on the ASX. It is a formal announcement related to capital raising and securities issuance rather than a financial report or earnings release. The content aligns with a Capital/Financing Update, specifically an announcement of new share issuance and related details. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2007-12-02 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.